James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Under Armour Inc: UA Soars on Q4 Earnings Beat

Under Armour (UA) may be priced at a ridiculous valuation, but story stocks don't trade on valuation -- they trade based on chatter.

Facebook Leaves No Doubt … It’s Awesome (FB)

Facebook (FB) posted "too good to be true" numbers for its fourth quarter, and yet, more of the same is in the cards.

Apple Inc. Is Now Officially Primed for a Bounce (AAPL)

Apple (AAPL) is getting trashed again today, but rumors of its death have been greatly exaggerated.

Why Energy Transfer Equity LP (ETE), Textron Inc. (TXT) and VMware, Inc. (VMW) Are 3 of Today’s Worst Stocks

Energy Transfer Equity (ETE), Textron (TXT) and VMware (VMW) were each doomed from the start of trading on Wednesday.

9 Biotech Stocks That Will Go Boom or Bust

A bunch of biotech stocks are knocking on the door of news that could prove to be very good or very bad.